Role of oxidative stress and the antioxidant network in cutaneous carcinogenesis

International Journal of Dermatology

Volumn 43, Issue 5, 2004, Pages 326-335

  Sander, Christina S ^a,b   Chang, Hong ^a,b   Hamm, Florian ^a,b   Elsner, Peter ^a,b   Thiele, Jens J ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CAROTENOID; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; CYTOCHROME P450 REDUCTASE; DIMETHYLBENZ[A]ANTHRACENE; EPIGALLOCATECHIN GALLATE; FAS ANTIGEN; FAS LIGAND; FREE RADICAL; GINGER EXTRACT; GLUTATHIONE; GLUTATHIONE REDUCTASE; GREEN TEA EXTRACT; MANGANESE SUPEROXIDE DISMUTASE; POLYPHENOL DERIVATIVE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; RESVERATROL; SILYMARIN; SUPEROXIDE DISMUTASE; UBIQUINONE; UNINDEXED DRUG;

AEROBIC METABOLISM; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CELL CULTURE; CANCER INHIBITION; CELL DAMAGE; DRUG EFFICACY; HUMAN; INFLAMMATION; KERATINOCYTE; LUNG CANCER; MELANOCYTE; MELANOMA; MELANOMA CELL; NONHUMAN; OXIDATIVE STRESS; PREVALENCE; RADIATION DOSE; RADIATION EXPOSURE; REVIEW; SKIN CANCER; SKIN CARCINOGENESIS; SOLAR RADIATION; SUPPLEMENTATION; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; ULTRAVIOLET RADIATION;

ANTIOXIDANTS; HUMANS; OXIDATIVE STRESS; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 2642573655     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2004.02222.x     Document Type: Review

References (118)

1. Black HS, deGruijl FR, Forbes PD, et al. Photocarcinogenesis: an overview. J Photochem Photobiol B 1997; 40: 29-47.
2. Harris RB, Griffith K, Moon TE. Trends in the incidence of nonmelanoma skin cancers in southeastern Arizona, 1985-96. J Am Acad Dermatol 2001; 45: 528-536.
3. Armstrong BK, Kricker A. Cutaneous melanoma. Cancer Surv 1994; 20: 219-240.
4. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 1994; 30: 774-778.
5. Gloster HM Jr, Brodland DG. The epidemiology of skin cancer. Dermatol Surg 1996; 22: 217-226.
6. Urbach F. Ultraviolet radiation and skin cancer of humans. J Photochem Photobiol B 1997; 40: 3-7.
7. Corona R, Dogliotti E, D'Errico M, et al. Risk factors for basal cell carcinoma in a Mediterranean population: role of recreational sun exposure early in life. Arch Dermatol 2001; 137: 1162-1168.
8. Peak MJ, Peak JG. Solar Ultraviolet Effects on Mammalian Cell DNA. In: Fuchs J, Packer L, eds. Oxidative Stress in Dermatology. New York, Basel, Hong Kong: Marcel Dekker, 1993: 169-186.
9. de Gruijl FR. Photocarcinogenesis. UVA vs UVB. Meth Enzymol 2000; 319: 359-366.
10. Hussain SP, Hofseth LJ, Harris CC. Radical causes of cancer. Nat Rev Cancer 2003; 3: 276-285.
11. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420: 860-867.
12. 2 is an important mediator of UVB-induced EGF-receptor phosphorylation in cultured keratinocytes. J Invest Dermatol 1998; 110: 966-971.
13. Peus D, Vasa RA, Beyerle A, et al. UVB activates ERK1/2. and p38 signaling pathways via reactive oxygen species in cultured keratinocytes. J Invest Dermatol 1999; 112: 751-756.
14. 2 is required for UVB-induced EGF receptor and downstream signaling pathway activation. Free Radic Biol Med 1999; 27: 1197-1202.
15. Peus D, Vasa RA, Meves A, et al. UVB-induced epidermal growth factor receptor phosphorylation is critical for downstream signaling and keratinocyte survival. Photochem Photobiol 2000; 72: 135-140.
16. Sies H. Oxidative stress. In: Sies H, ed. Oxidative Stress. San Diego: Academic Press, 1991.
17. Darr D, Fridovich I. Free radicals in cutaneous biology. J Invest Dermatol 1994; 102: 671-675.
18. Thiele JJ, Dreher F, Packer L. Antioxidant defense systems in skin. In: Elsner P, Maibach H, eds. Cosmeceuticals, Drugs Vs. Cosmetics. New York: Marcel Dekker, 2000: 145-187.
19. Hofseth LJ, Saito S, Hussain SP, et al. Nitric oxide-induced cellular stress and p53 activation in chronic inflammation. Proc Natl Acad Sci USA 2003; 100: 143-148.
20. Hofseth LJ, Hussain SP, Wogan GN, et al. Nitric oxide in cancer and chemoprevention1. Free Radic Biol Med 2003; 34: 955-968.
21. Marnett LJ, Oxyradicals, DNA damage. Carcinogenesis 2000; 21: 361-370.
22. Black HS. The defensive role of antioxidants in skin carcinogenesis. In: Fuchs J, Packer L, eds. Oxidative Stress in Dermatology. New York: Marcel Dekker, 1993: 243-269.
23. Perchellet JP, Perchellet EM, Gali HU, et al. Oxidant stress and multistage skin carcinogenesis. In: Mukhtar H, ed. Skin Cancer: Mechanisms and Human Relevance. Boca Raton: CRC Press, 1995: 145-180.
24. Taffe BG, Kensler TW. Free radicals and signal transduction in tumor promotion. In: Colburn NH, ed. Genes and Signal Transduction in Multistage Carcinogenesis. New York: Marcel Dekker, 1989: 391-397.
25. Quintanilla M, Brown K, Ramsden M, et al. Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature 1986; 322: 78-80.
26. Ioannides C, Parke DV. The cytochromes P-448 - a unique family of enzymes involved in chemical toxicity and carcinogenesis. Biochem Pharmacol 1987; 36: 4197-4207.
27. Ordman AB, Cleaveland JS, Boutwell RK. 12-O-tetradecanoylphorbol-13-acetate promotes tumors prior to initiation in two-stage promotion. Cancer Lett 1985; 29: 79-84.
28. Kawanishi S, Hiraku Y, Oikawa S. Mechanism of guanine-specific DNA damage by oxidative stress and its role in carcinogenesis and aging. Mutat Res 2000; 488: 65-76.
29. Frenkel K, Gleichauf C. Hydrogen peroxide formation by cells treated with a tumor promoter. Free Radic Res Commun 1991; 12-13: 783-794.
30. Schafer A, Wieser RJ, Romero F, et al. Reduction of glutathione content by 12-O-tetradecanoylphorbol-13-acetate in confluent, but not in sparse cultures of human diploid fibroblasts. Carcinogenesis 1990; 11: 697-699.
31. Smith JS Jr, Wey HE, Leikauf GD, et al. JB6 murine epidermal cell lines sensitive and resistant to 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced transformation exhibit differential arachidonic acid metabolism in response to TPA and the calcium ionophore A23187. Carcinogenesis 1992; 13: 189-192.
32. Lillehaug JR, Berge RK. The tumour promoter 12-O-tetradecanoylphorbol-13-acetate increases the activities of some peroxisome-associated enzymes in in vitro cell culture. Br J Cancer 1986; 53: 121-127.
33. Elliott BM, Dodd NJ, Elcombe CR. Increased hydroxyl radical production in liver peroxisomal fractions from rats treated with peroxisome proliferators. Carcinogenesis 1986; 7: 795-799.
34. Kasai H, Okada Y, Nishimura S, et al. Formation of 8-hydroxydeoxyguanosine in liver DNA of rats following long-term exposure to a peroxisome proliferator. Cancer Res 1989; 49: 2603-2605.
35. Perchellet EM, Perchellet JP. Characterization of the hydroperoxide response observed in mouse skin treated with tumor promoters in vivo. Cancer Res 1989; 49: 6193-6201.
36. Taniguchi N, Pickett CB, Griffith OW. Oxy radicals and antioxidative responses in cancer: 12th Sapporo Cancer Seminar. Cancer Res 1993; 53: 3207-3210.
37. Cerutti PA, Trump BF. Inflammation and oxidative stress in carcinogenesis. Cancer Cells 1991; 3: 1-7.
38. Cerutti PA, Larrson R, Krupitza G. Pathophysiological mechanisms of oxidants. In: Cerutti PA, Fridovich I, McCord JM, eds. Oxy Radicals in Molecular Biology and Pathology. New York: Alan R. Liss, 1988: 493-497.
39. Hennings H, Shores R, Mitchell P, et al. Induction of papillomas with a high probability of conversion to malignancy. Carcinogenesis 1985; 6: 1607-1610.
40. Reddy AL, Fialkow PJ. Influence of dose of initiator on two-stage skin carcinogenesis in BALB/c mice with cellular mosaicism. Carcinogenesis 1988; 9: 751-754.
41. Athar M, Lloyd JR, Bickers DR, et al. Malignant conversion of UV radiation and chemically induced mouse skin benign tumors by free-radical-generating compounds. Carcinogenesis 1989; 10: 1841-1845.
42. Warren BS, Naylor MF, Winberg LD, et al. Induction and inhibition of tumor progression. Proc Soc Exp Biol Medical 1993; 202: 9-15.
43. O'Connell JF, Klein-Szanto AJ, DiGiovanni DM, et al. Enhanced malignant progression of mouse skin tumors by the free-radical generator benzoyl peroxide. Cancer Res 1986; 46: 2863-2865.
44. Kensler TW, Egner PA, Moore KG, et al. Role of inflammatory cells in the metabolic activation of polycyclic aromatic hydrocarbons in mouse skin. Toxicol Appl Pharmacol 1987; 90: 337-346.
45. Trush MA, Seed JL, Kensler TW. Oxidant-dependent metabolic activation of polycyclic aromatic hydrocarbons by phorbol ester-stimulated human polymorphonuclear leukocytes. possible link between inflammation and cancer. Proc Natl Acad Sci USA 1985; 82: 5194-5198.
46. Loft S, Poulsen HE. Cancer risk and oxidative DNA damage in man. J Mol Med 1996; 74: 297-312.
47. Marnett LJ. Polycyclic aromatic hydrocarbon oxidation during prostaglandin biosynthesis. Life Sci 1981; 29: 531-546.
48. Marnett LJ. Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res 1992; 52: 5575-5589.
49. Mates JM, Perez-Gomez C, Nunez de Castro I. Antioxidant enzymes and human diseases. Clin Biochem 1999; 32: 595-603.
50. Maeda H, Akaike T. Nitric oxide and oxygen radicals in infection, inflammation, and cancer. Biochemistry 1998; 63: 854-865.
51. Coussens LM, Werb Z. Inflammatory cells and cancer: think different!. J Exp Med 2001; 193: F23-F26.
52. Clydesdale GJ, Dandie GW, Muller HK. Ultraviolet light induced injury: Immunological and inflammatory effects. Immunol Cell Biol 2001; 79: 547-568.
53. Chan WH, Yu JS. Inhibition of UV irradiation-induced oxidative stress and apoptotic biochemical changes in human epidermal carcinoma A431 cells by genistein. J Cell Biochem 2000; 78: 73-84.
54. Kulms D, Schwarz T. Molecular mechanisms of UV-induced apoptosis. Photodermatol Photoimmunol Photomed 2000; 16: 195-201.
55. Einspahr JG, Alberts DS, Warneke JA, et al. Relationship of p53 mutations to epidermal cell proliferation and apoptosis in human UV-induced skin carcinogenesis. Neoplasia 1999; 1: 468-475.
56. Smith ML, Chen IT, Zhan Q, et al. Involvementof the p53 tumor suppressor in repair of u.v.-type DNA damage. Oncogene 1995; 10: 1053-1059.
57. Renzing J, Hansen S, Lane DP. Oxidative stress is involved in the UV activation of p53. J Cell Sci 1996; 109: 1105-1112.
58. Milne DM, Campbell LE, Campbell DG, et al. p53 is phosphorylated in vitro and in vivo by an ultraviolet radiation- induced protein kinase characteristic of the c-Jun kinase, JNK1. J Biol Chem 1995; 270: 5511-5518.
59. Zhan Q, Carrier F, Fornace AJ Jr. Induction of cellular p53 activity by DNA-damaging agents and growth arrest. Mol Cell Biol 1993; 13: 4242-4250.
60. Kuerbitz SJ, Plunkett BS, Walsh WV, et al. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA 1992; 89: 7491-7495.
61. Brash DE, Ziegler A, Jonason AS, et al. Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion. J Invest Dermatol Symp Proc 1996; 1: 136-142.
62. Harris CC. Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies. J Natl Cancer Inst 1996; 88: 1442-1455.
63. Kannan K, Jain SK. Oxidative stress and apoptosis. Pathophysiology 2000; 7: 153-163.
64. Gobert C, Bracco L, Rossi F, et al. Modulation of DNA topoisomerase I activity by p53. Biochemistry 1996; 35: 5778-5786.
65. Hill LL, Ouhtit A, Loughlin SM, et al. Fas ligand: a sensor for DNA damage critical in skin cancer etiology. Science 1999; 285: 898-900.
66. Gutierrez-Steil C, Wrone-Smith T, Sun X, et al. Sunlight-induced basal cell carcinoma tumor cells and ultraviolet-B-irradiated psoriatic plaques express Fas ligand (CD95L). J Clin Invest 1998; 101: 33-39.
67. Friesen C, Fulda S, Debatin KM. Induction of CD95 ligand and apoptosis by doxorubicin is modulated by the redox state in chemosensitive- and drug-resistant tumor cells. Cell Death Differ 1999; 6: 471-478.
68. Shindo Y, Hashimoto T. Ultraviolet B-induced cell death in four cutaneous cell lines exhibiting different enzymatic, antioxidant defences: involvement of apoptosis. J Dermatol Sci 1998; 17: 140-150.
69. Lawley W, Doherty A, Denniss S, et al. Rapid lupus autoantigen relocalization and reactive oxygen species accumulation following ultraviolet irradiation of human keratinocytes. Rheumatology 2000; 39: 253-261.
70. 2-induced apoptosis in keratinocytes. Biol Chem 2002; 383: 703-708.
71. Flohe L, Brigelius-Flohe R, Saliou C, et al. Redox regulation of NF-kappa B activation. Free Rad Biol Med 1997; 22: 1115-1126.
72. Fuchs J, Huflejt ME, Rothfuss LM, et al. Acute effects of near ultraviolet and visible light on the cutaneous antioxidant defense system. Photochem Photobiol 1989; 50: 739-744.
73. Fuchs J, Huflejt ME, Rothfuss LM, et al. Impairment of enzymic and nonenzymic antioxidants in skin by UVB irradiation. J Invest Dermatol 1989; 93: 769-773.
74. Sasaki H, Akamatsu H, Horio T. Protective role of copper, zinc superoxide dismutase against UVB-induced injury of the human keratinocyte cell line HaCaT. J Invest Dermatol 2000; 114: 502-507.
75. Sasaki H, Akamatsu H, Horio T. Effects of a single exposure to UVB radiation on the activities and protein levels of copper-zinc and manganese superoxide dismutase in cultured human keratinocytes. Photochem Photobiol 1997; 65: 707-713.
76. Poswig A, Wenk J, Brenneisen P, et al. Adaptive antioxidant response of manganese-superoxide dismutase following repetitive UVA irradiation. J Invest Dermatol 1999; 112: 13-18.
77. Meewes C, Brenneisen P, Wenk J, et al. Adaptive antioxidant response protects dermal fibroblasts from UVA-induced phototoxicity. Free Radic Biol Med 2001; 30: 238-147.
78. Shindo Y, Hashimoto T. Time course of changes in antioxidant enzymes in human skin fibroblasts after UVA irradiation. J Dermatol Sci 1997; 14: 225-232.
79. Punnonen K, Puntala A, Ahotupa M. Effects of ultraviolet A and B irradiation on lipid peroxidation and activity of the antioxidant enzymes in keratinocytes in culture. Photodermatol Photoimmunol Photomed 1991; 8: 3-6.
80. Punnonen K, Autio P, Kiistala U, et al. In vivo effects of solar-simulated UV irradiation on antioxidant enzymes and lipid peroxidation in human epidermis. Br J Dermatol 1991; 125: 18-20.
81. Shindo Y, Witt E, Han D, et al. Dose-response effects of acute ultraviolet irradiation on antioxidants and molecular markers of oxidation in murine epidermis and dermis. J Invest Dermatol 1994; 102: 470-475.
82. Punnonen K, Lehtola K, Autio P, et al. Chronic UVB irradiation induces superoxide dismutase activity in human epidermis in vivo. Photochem Photobiol 1995; 30: 43-48.
83. Sander CS, Chang H, Salzmann S, et al. Photoaging is associated with protein oxidation in human skin in vivo. J Invest Dermatol 2002; 118: 618-625.
84. Thiele JJ, Traber MG, Packer L. Depletion of human stratum corneum vitamin E. an early and sensitive in vivo marker of UV induced photo-oxidation. J Invest Dermatol 1998; 110: 756-761.
85. Thiele JJ, Schroeter C, Hsieh SN, et al. The antioxidant network of the stratum corneum. In: Thiele J, Elsner P, eds. Oxidants and Antioxidants in Cutaneous Biology. Basel: Karger, 2001: 26-42.
86. Picardo M, Grammatico P, Roccella F, et al. Imbalance in the antioxidant pool in melanoma cells and normal melanocytes from patients with melanoma. J Invest Dermatol 1996; 107: 322-326.
87. Meyskens FL Jr, Chau HV, Tohidian N, et al. Luminol-enhanced chemiluminescent response of human melanocytes and melanoma cells to hydrogen peroxide stress. Pigment Cell Res 1997; 10: 184-189.
88. Bittinger F, Gonzalez-Garcia JL, Klein CL, et al. Production of superoxide by human malignant melanoma cells. Melanoma Res 1998; 8: 381-387.
89. Offner FA, Wirtz HC, Schiefer J, et al. Interaction of human malignant melanoma (ST-ML-12) tumor spheroids with endothelial cell monolayers. Damage to endothelium by oxygen-derived free radicals. Am J Pathol 1992; 141: 601-610.
90. Grammatico P, Maresca V, Roccella F, et al. Increased sensitivity to peroxidizing agents is correlated with an imbalance of antioxidants in normal melanocytes from melanoma patients. Exp Dermatol 1998; 7: 205-212.
91. Picardo M, Maresca V, Eibenschutz L, et al. Correlation between antioxidants and phototypes in melanocytes cultures. A possible link of physiologic and pathologic relevance. J Invest Dermatol 1999; 113: 424-425.
92. Rabilloud T, Asselineau D, Miquel C, et al. Deficiency in catalase activity correlates with the appearance of tumor phenotype in human keratinocytes. Int J Cancer 1990; 45: 952-956.
93. Lehtola K, Laurikainen L, Leino L, et al. Antioxidant enzymes are elevated in dimethylbenz (a) anthracene-induced neoplastic murine keratinocytes containing an active ras-Ha oncogene. J Cancer Res Clin Oncol 1995; 121: 402-406.
94. Vural P, Canbaz M, Selcuki D. Plasma antioxidant defense in actinic keratosis and basal cell carcinoma. J Eur Acad Dermatol Venereol 1999; 13: 96-101.
95. Kobayashi T, Matsumoto M, Iizuka H, et al. Superoxide dismutase in psoriasis, squamous cell carcinoma and basal cell epithelioma: an immunohistochemical study. Br J Dermatol 1991; 124: 555-559.
96. Borrello S, Seccia A, Galeotti T, et al. Protective enzymes in human epidermal carcinomas and psoriasis. Arch Dermatol Res 1984; 276: 338-340.
97. Schadendorf D, Zuberbier T, Diehl S, et al. Serum manganese superoxide dismutase is a new tumour marker for malignant melanoma. Melanoma Res 1995; 5: 351-353.
98. Sander CS, Hamm F, Elsner P, et al. Oxidative stress in malignant melanoma and non-melanoma skin cancer. Br J Dermatol 2003; 148: 913-922.
99. Sies H. Strategies of antioxidant defense. Eur J Biochem 1993; 215: 213-219.
100. Krinsky NI. Antioxidant functions of carotenoids. Free Radic Biol Med 1989; 7: 617-635.
101. Epstein JH. Effects of beta-carotene on ultraviolet induced cancer formation in the hairless mouse skin. Photochem Photobiol 1977; 25: 211-213.
102. Mathews-Roth MM, Krinsky NI. Carotenoid dose level and protection against UV-B induced skin tumors. J Photochem Photobiol B Biol 1985; 42: 35-38.
103. Black HS, Lambert CR. Radical reactions of carotenoids and potential influence on UV carcinogenesis. In: Thiele JJ, Elsner P, eds. Oxidants and Antioxidants in Cutaneous Biology. Basel: Karger, 2001: 140-156.
104. Greenberg ER, Baron JA, Stukel TA, et al. A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin. The Skin Cancer Prevention Study Group. N Engl J Med 1990; 323: 789-795.
105. Albanes D, Heinonen OP, Taylor PR, et al. Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst 1996; 88: 1513-1515.
106. Ahmad N, Katiyar SK, Mukhtar H. Antioxidants in chemoprevention of skin cancer. In: Thiele JJ, Elsner P, eds. Oxidants and Antioxidants in Cutaneous Biology. Basel: Karger, 2001: 128-139.
107. Katiyar SK, Matsui MS, Elmets CA, et al. Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea reduces UVB-induced inflammatory responses and infiltration of leukocytes in human skin. Photochem Photobiol 1999; 69: 148-153.
108. Afaq F, Adhami VM, Ahmad N, et al. Inhibition of ultraviolet B-mediated activation of nuclear factor kappaB in normal human epidermal keratinocytes by green tea Constituent (-)-epigallocatechin-3-gallate. Oncogene 2003; 22: 1035-1044.
109. Katiyar SK, Rupp CO, Korman NJ, et al. Inhibition of 12-O-tetradecanoylphorbol-13-acetate and other skin tumor-promoter-caused induction of epidermal interleukin-1-alpha mRNA and protein expression in SENCAR mice by green tea polyphenols. J Invest Dermatol 1995; 105: 394-398.
110. Katiyar SK, Ahmad N, Mukhtar H. Green tea and skin. Arch Dermatol 2000; 136: 989-994.
111. Jang JH, Surh YJ. Protective effects of resveratrol on hydrogen peroxide-induced apoptosis in rat pheochromocytoma (PC12) cells. Mutat Res 2001; 496: 181-190.
112. Jang M, Pezzuto JM. Effects of resveratrol on 12-O-tetradecanoylphorbol-13-acetate-induced oxidative events and gene expression in mouse skin. Cancer Lett 1998; 134: 81-89.
113. Hamanaka H, Miyachi Y, Imamura S. Photoprotective effect of topically applied superoxide dismutase on sunburn reaction in comparison with sunscreen. J Dermatol 1990; 17: 595-598.
114. Lopez-Torres M, Thiele JJ, Shindo Y, et al. Topical application of alpha-tocopherol modulates the antioxidant network and diminishes ultraviolet-induced oxidative damage in murine skin. Br J Dermatol 1998; 138: 207-215.
115. Dreher F, Maibach H. Protective effects of topical antioxidants in humans. In: Thiele JJ, Elsner P, eds. Oxidants and Antioxidants in Cutaneous Biology. Basel: Karger, 2001: 157-164.
116. Steenvoorden DP, van Henegouwen GM. The use of endogenous antioxidants to improve photoprotection. J Photochem Photobiol B 1997; 411: 1-10.
117. Hadshiew I, Stäb F, Untiedt S, et al. Effects of topically applied antioxidants in experimentally provoked polymorphous light eruption. Dermatology 1997; 195: 362-368.
118. Dreher F, Gabard B, Schwindt DA, et al. Topical melatonin in combination with vitamins E and C protects skin from UV-induced erythema: a human study in vivo. Br J Dermatol 1998; 139: 332-339.